2011 SABCS Public All Photos
Read More
San Antonio, TX - SABCS 2011 San Antonio Breast Cancer Symposium: Luca Gianni discusses S4-8. First results of AVEREL, a randomized phase III trial to evaluate bevacizumab (BEV) in combination with trastuzumab (H) + docetaxel (DOC) as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer (LR/mBC) during the General Session 4 at the 2011 San Antonio Breast Cancer Symposium here today, Thursday December 8, 2011. Over 9,000 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Date: Thursday December 8, 2011 Photo by © SABCS/Todd Buchanan 2011 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154.
